4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001780088-25-000006
CHIEF MEDICAL OFFICER sold 5,358 shares at an average $31.19 ($167,115)
- CHIEF MEDICAL OFFICER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ticho Barry · CHIEF MEDICAL OFFICER
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | 25,156 | D | ||
| 2025-12-04 | Sale : show line 2 in the form 10b5-1 | −1,373 | $30.76 | $42,238 | 23,783 | D |
| 2025-12-04 | Sale : show line 3 in the form 10b5-1 | −323 | $31.32 | $10,115 | 23,460 | D |
| 2025-12-05 | Sale : show line 4 in the form 10b5-1 | −1,673 | $31.33 | $52,416 | 21,787 | D |
| 2025-12-05 | Sale : show line 5 in the form 10b5-1 | −1,989 | $31.35 | $62,346 | 19,798 | D |
| Open-market sales · 5,358 sh · avg $31.19 · $167,115 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-03 | Exercise or conversion : show line 6 in the form 10b5-1 Performance Stock Units | −10,000 | 0 | D |
Loading xslF345X05/form4-12062025_011222.xml…